For instance, polymeric NPs modified with EGF can target GBM cells overexpressing EGFR, while VEGF-modified polymeric NPs can enhance targeting of the TME, specifically within the tumor vasculature (Khan et al., 2022). This evidence concerns the gene EGFR and neoplasm.